BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.7749
+0.0008 (0.10%)
At close: Sep 12, 2025, 4:00 PM EDT
0.7900
+0.0151 (1.95%)
After-hours: Sep 12, 2025, 7:19 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $45.50 million as of September 12, 2025. Its market cap has decreased by -47.41% in one year.
Market Cap
45.50M
Enterprise Value
33.34M
1-Year Change
-47.41%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $45.50M, a decrease of -92.12%. That is a compound annual growth rate of -41.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 45.50M | 32.65% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |